Back
McEwen Mining 10K Form
Buy
51
MUX
McEwen Mining
Last Price:
11.21
Seasonality Move:
2.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | MUX/McEwen Mining Quarterly |
| 2023-08-09 | 10Q | MUX/McEwen Mining Quarterly |
| 2023-05-08 | 10Q | MUX/McEwen Mining Quarterly |
| 2022-11-04 | 10Q | MUX/McEwen Mining Quarterly |
| 2022-08-10 | 10Q | MUX/McEwen Mining Quarterly |
| 2022-05-10 | 10Q | MUX/McEwen Mining Quarterly |
Receive MUX News And Ratings
See the #1 stock for the next 7 days that we like better than MUX
MUX Financial Statistics
Sales & Book Value
| Annual Sales: | $166.23M |
|---|---|
| Cash Flow: | $8.58M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.16 |
| Price / Book: | 1.1 |
Profitability
| EPS (TTM): | 1.15000 |
|---|---|
| Net Income (TTM): | $55.3M |
| Gross Margin: | $17.78M |
| Return on Equity: | 12.23% |
| Return on Assets: | 9.13% |
McEwen Mining Earnings Forecast
Key McEwen Mining Financial Ratios
- The Gross Profit Margin over the past 40 years for MUX is 10.70%.
- The Selling, General & Administrative Expenses for MUX have been equal to 9.29% of Gross Profit Margin.
- The Research & Development expenses have been 5.69% of Revenue.
- The Interest Expense is -9.61% of Operating Income.
- The Net Earning history of MUX is 33.27% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 14 years.
McEwen Mining Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | MUX |
| CUSIP: | 58039P |
| Website: | mcewenmining.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 1.76 |
| Quick Ratio: | 0.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.67 |
|---|---|
| Forward P/E Ratio: | 0 |
MUX Technical Analysis vs Fundamental Analysis
Buy
51
McEwen Mining (MUX)
is a Buy
Is McEwen Mining a Buy or a Sell?
-
McEwen Mining stock is rated a Buy
The current McEwen Mining [MUX] share price is $11.22. The Score for MUX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.